204 related articles for article (PubMed ID: 27485451)
1. Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth.
Haesen D; Abbasi Asbagh L; Derua R; Hubert A; Schrauwen S; Hoorne Y; Amant F; Waelkens E; Sablina A; Janssens V
Cancer Res; 2016 Oct; 76(19):5719-5731. PubMed ID: 27485451
[TBL] [Abstract][Full Text] [Related]
2. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma.
Shih IeM; Wang TL
J Pathol; 2011 May; 224(1):1-4. PubMed ID: 21432855
[TBL] [Abstract][Full Text] [Related]
3. PPP2R1A mutations are common in the serous type of endometrial cancer.
Nagendra DC; Burke J; Maxwell GL; Risinger JI
Mol Carcinog; 2012 Oct; 51(10):826-31. PubMed ID: 21882256
[TBL] [Abstract][Full Text] [Related]
4. Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2A.
Haines K; Huang GS
Cancer Res; 2019 Aug; 79(16):4009-4010. PubMed ID: 31416848
[TBL] [Abstract][Full Text] [Related]
5. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
[TBL] [Abstract][Full Text] [Related]
6. Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous Carcinoma.
O'Connor CM; Taylor SE; Miller KM; Hurst L; Haanen TJ; Suhan TK; Zawacki KP; Noto FK; Trako J; Mohan A; Sangodkar J; Zamarin D; DiFeo A; Narla G
Cancer Res; 2022 Feb; 82(4):721-733. PubMed ID: 34921012
[TBL] [Abstract][Full Text] [Related]
7. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
[TBL] [Abstract][Full Text] [Related]
8. The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis.
Taylor SE; O'Connor CM; Wang Z; Shen G; Song H; Leonard D; Sangodkar J; LaVasseur C; Avril S; Waggoner S; Zanotti K; Armstrong AJ; Nagel C; Resnick K; Singh S; Jackson MW; Xu W; Haider S; DiFeo A; Narla G
Cancer Res; 2019 Aug; 79(16):4242-4257. PubMed ID: 31142515
[TBL] [Abstract][Full Text] [Related]
9. Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.
Jeong AL; Han S; Lee S; Su Park J; Lu Y; Yu S; Li J; Chun KH; Mills GB; Yang Y
Sci Rep; 2016 Jun; 6():27391. PubMed ID: 27272709
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors.
O'Connor CM; Leonard D; Wiredja D; Avelar RA; Wang Z; Schlatzer D; Bryson B; Tokala E; Taylor SE; Upadhyay A; Sangodkar J; Gingras AC; Westermarck J; Xu W; DiFeo A; Brautigan DL; Haider S; Jackson M; Narla G
Oncogene; 2020 Jan; 39(3):703-717. PubMed ID: 31541192
[TBL] [Abstract][Full Text] [Related]
11. Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival.
Strack S; Cribbs JT; Gomez L
J Biol Chem; 2004 Nov; 279(46):47732-9. PubMed ID: 15364932
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 2A Aα regulates Aβ protein expression and stability.
O'Connor CM; Hoffa MT; Taylor SE; Avelar RA; Narla G
J Biol Chem; 2019 Apr; 294(15):5923-5934. PubMed ID: 30796164
[TBL] [Abstract][Full Text] [Related]
13. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
Houge G; Haesen D; Vissers LE; Mehta S; Parker MJ; Wright M; Vogt J; McKee S; Tolmie JL; Cordeiro N; Kleefstra T; Willemsen MH; Reijnders MR; Berland S; Hayman E; Lahat E; Brilstra EH; van Gassen KL; Zonneveld-Huijssoon E; de Bie CI; Hoischen A; Eichler EE; Holdhus R; Steen VM; Døskeland SO; Hurles ME; FitzPatrick DR; Janssens V
J Clin Invest; 2015 Aug; 125(8):3051-62. PubMed ID: 26168268
[TBL] [Abstract][Full Text] [Related]
14. PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer.
Gonzalez-Bosquet J; Bakkum-Gamez JN; Weaver AL; McGree ME; Dowdy SC; Famuyide AO; Kipp BR; Halling KC; Couch FJ; Podratz KC
Gynecol Oncol; 2021 Jul; 162(1):182-189. PubMed ID: 33867147
[TBL] [Abstract][Full Text] [Related]
15. PP2A-mTOR-p70S6K/4E-BP1 axis regulates M1 polarization of pulmonary macrophages and promotes ambient particulate matter induced mouse lung injury.
Chen S; Chen L; Ye L; Jiang Y; Li Q; Zhang H; Zhang R; Li H; Yu D; Zhang R; Niu Y; Zhao Q; Liu J; Ouyang G; Aschner M; Zheng Y; Zhang L; Chen W; Li D
J Hazard Mater; 2022 Feb; 424(Pt C):127624. PubMed ID: 34740159
[TBL] [Abstract][Full Text] [Related]
16. Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.
Menderes G; Clark M; Santin AD
Discov Med; 2016 Apr; 21(116):293-303. PubMed ID: 27232515
[TBL] [Abstract][Full Text] [Related]
17. Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.
Walter G; Ruediger R
Cell Cycle; 2012 Feb; 11(3):451-9. PubMed ID: 22262169
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
[TBL] [Abstract][Full Text] [Related]
19. Scaffold subunit Aalpha of PP2A is essential for female meiosis and fertility in mice.
Hu MW; Wang ZB; Jiang ZZ; Qi ST; Huang L; Liang QX; Schatten H; Sun QY
Biol Reprod; 2014 Jul; 91(1):19. PubMed ID: 24899574
[TBL] [Abstract][Full Text] [Related]
20. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
